Name | N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide |
---|---|
Synonyms | N-[(3R)-1-azabicyclo[2.2.2]octan-3-yl]furo[2,3-c]pyridine-5-carboxamide,hydrochloride |
Description | PHA-543613 is a potent, orally active, brain-penetrant and selective α7 nAChR agonist with a Ki of 8.8 nM. PHA-543613 displays selectivity for α7-nAChR over α3β4, α1β1γδ, α4β2 and 5-HT3 receptors[1]. PHA-543613 can be used for the cognitive deficits of Alzheimer's disease and schizophrenia research[2]. |
---|---|
Related Catalog | |
Target |
Ki: 8.8 nM (α7 nAChR)[1] |
In Vivo | PHA-543613 (0.3 mg/kg) successfully reverses Scopolamine-induced short-term memory deficits in rats[2]. |
References |
Molecular Formula | C15H17N3O2 |
---|---|
Molecular Weight | 271.31 |
Exact Mass | 307.10900 |
PSA | 58.37000 |
LogP | 2.78260 |
RIDADR | NONH for all modes of transport |
---|
Precursor 9 | |
---|---|
DownStream 0 |